权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Noninvasive Monitoring Glutathione Metabolism in Tumors

无创监测肿瘤中的谷胱甘肽代谢

基本信息

批准号：
7578281
负责人：
MICHAEL GAMCSIK
金额：
$ 26.68万
依托单位：
NORTH CAROLINA STATE UNIVERSITY RALEIGH
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
起止时间：
2006-03-17 至 2011-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7578281
关键词：
Address Aftercare Amino Acids Antioxidants Apoptosis Arts Biochemistry Biological Models Biomedical Engineering Biopsy Specimen Blood Vessels Buffers Cell Culture Techniques Cells Characteristics Clinical Research Defense Mechanisms Development Disulfides Drops Drug resistance Duke Comprehensive Cancer Center Enzymes Equilibrium Event Florida Funding Gene Expression Glioma Glutathione Glutathione Metabolism Pathway Growth Heterogeneity Infusion procedures Investigation Isotope Labeling Label Laboratories Magnetic Resonance Magnetic Resonance Imaging Malignant Neoplasms Mammary gland Measures Metabolic Metabolism Methods Modeling Monitor Normal tissue morphology North Carolina Oxidation-Reduction Patients Pilot Projects Play Process Proliferating Rattus Reproducibility Research Personnel Role Sampling Sampling Errors Stress System Testing Therapeutic Tissues Tumor Tissue Universities Variant Vascularization cancer cell cancer therapy chemotherapy design fibrosarcoma in vivo insight monolayer neoplastic cell programs research study response stable isotope success therapy resistant tumor tumor growth uptake

项目摘要

Glutathione is a ubiquitous tripeptide found in high concentration in normal tissue and is frequently elevated in tumors. Glutathione and its oxidized disulfide form the primary reduction/oxidation (redox) buffer in the cell. The cellular redox balance controls gene expression, differentiation, proliferation and apoptosis. In normal tissue, glutathione protects the cell from environmental stress and the cancer cell has adapted this defense mechanism to shield tumor cells from the effects of therapy. In cell culture, our laboratory has shown that glutathione metabolism is consistently increased in drug-resistant cancers. These findings are supported by a number of clinical studies relating glutathione metabolism to patient survival. However the clinical studies rely upon invasive repeated sampling of the tumor tissue since methods to monitor glutathione metabolism in intact rumors are lacking. Over the past two years, as part of an NTH-funded pilot project, we succeeded in developing a magnetic resonance method combined with stable isotope infusion to monitor glutathione metabolism in vivo. This proposal builds upon the feasibility established in the pilot project and plans to Use these methods to monitor glutathione metabolism non-invasively in R3230 mammary, 9L glioma and FSA fibrosarcoma tumors and drug-resistant variants in rats. Glutathione metabolism will be assessed in relation to tumor growth rate, vascularization and expression of key enzymes involved in redox metabolism. Since a drop in intracellular glutathione levels is one of the earliest events in apoptosis, therapy-induced changes in glutathione metabolism detected by magnetic resonance will be an early indicator of tumor response. Since altered redox balance appears to be a universal characteristic of proliferating cells in general and cancer in particular, methods to non-invasively monitor redox metabolism offers new insight into a process critical to planning and evaluating cancer therapy.

谷氨酰胺是一种普遍存在的三肽，在正常组织中以高浓度存在，并且在正常组织中经常升高。肿瘤的谷氨酸及其氧化的二硫化物形成细胞中的主要还原/氧化（氧化还原）缓冲液。细胞氧化还原平衡控制基因表达、分化、增殖和凋亡。正常组织，谷胱甘肽保护细胞免受环境压力，癌细胞已经适应了这种防御保护肿瘤细胞免受治疗影响的机制。在细胞培养中，我们的实验室已经证明，谷胱甘肽代谢在抗药性癌症中持续增加。这些发现得到了一个谷胱甘肽代谢与患者生存率相关的临床研究数量。然而，临床研究依赖于在肿瘤组织的侵入性重复取样后，由于监测完整组织中谷胱甘肽代谢的方法谣言缺乏。在过去的两年里，作为NTH资助的试点项目的一部分，我们成功地磁共振结合稳定同位素灌注法监测谷胱甘肽体内代谢该提案建立在试点项目中确定的可行性基础上，并计划使用这些方法用于非侵入性监测R3230乳腺、9 L胶质瘤和FSA中的谷胱甘肽代谢，纤维肉瘤肿瘤和耐药变体。将评估与以下方面相关的谷氨酰胺代谢肿瘤生长速率、血管形成和参与氧化还原代谢的关键酶的表达。由于细胞内谷胱甘肽水平的下降是细胞凋亡中最早的事件之一，通过磁共振检测的谷胱甘肽代谢将是肿瘤反应的早期指标。以来氧化还原平衡的改变似乎是一般增殖细胞和癌症的普遍特征，特别是，非侵入性监测氧化还原代谢的方法提供了对关键过程的新见解，规划和评估癌症治疗。